FDA is letting pharmacists prescribe Pfizer's Paxlovid but won't do the same for Merck's Lagevrio

Since they were authorized a day apart in December, Pfizer’s Paxlovid and Merck and Ridgeback’s Lagevrio have been linked as twin oral antiviral COVID-19 treatments.